drugset / Trial / NCT00338962
Naltrexone & SSRI in Alcoholics With Depression/PTSD
RandomizedFactorialTriple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy of naltrexone in combination with an SSRI to reduce alcohol consumption in alcoholic patients with comorbid PTSD and depression. We hypothesize that the combination of naltrexone and SSRI will exhibit a greater decrease in alcohol consumption than that seen with treatment with SSRI alone, or with a combination of another class of antidepressant and naltrexone. We also hypothesize that SSRI will be effective in treating PTSD and depressive symptoms and naltrexone will be well tolerated.
Timeline
- Start
- 2001-10
- Primary completion
- 2015-07
- Completion
- 2015-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Desipramine | Small molecule | 200 mg | — |
| Comparator | Naltrexone | Small molecule | 50 mg | — |
| Comparator | Paroxetine | Small molecule | 40 mg | — |